LOTRIMIN ULTRA Drug Patent Profile
✉ Email this page to a colleague
When do Lotrimin Ultra patents expire, and what generic alternatives are available?
Lotrimin Ultra is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in LOTRIMIN ULTRA is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lotrimin Ultra
A generic version of LOTRIMIN ULTRA was approved as butenafine hydrochloride by TARO on November 16th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOTRIMIN ULTRA?
- What are the global sales for LOTRIMIN ULTRA?
- What is Average Wholesale Price for LOTRIMIN ULTRA?
Summary for LOTRIMIN ULTRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 4 |
What excipients (inactive ingredients) are in LOTRIMIN ULTRA? | LOTRIMIN ULTRA excipients list |
DailyMed Link: | LOTRIMIN ULTRA at DailyMed |
Recent Clinical Trials for LOTRIMIN ULTRA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bayer | Phase 3 |
Taro Pharmaceuticals USA | Phase 1 |
Pharmacology for LOTRIMIN ULTRA
Drug Class | Benzylamine Antifungal |
US Patents and Regulatory Information for LOTRIMIN ULTRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | LOTRIMIN ULTRA | butenafine hydrochloride | CREAM;TOPICAL | 021307-001 | Dec 7, 2001 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |